Delivery Order SPE2DB25D3005-SPE2DB25FQBMF
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,404.40 for the delivery of 25 mg capsules of the medication atomoxetine hydrochloride. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 24, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 25 mg capsules. The contract has a ceiling value of $1,134.63 and runs through January 2, 2025. It is a firm-fixed-price delivery order contract, with no set-aside requirements indicated.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,561,888,754 units of Atomoxetine HCL 18 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The Delivery Order contract, valued at $4,381.89, has a firm fixed price and an ultimate completion date of August 22, 2023. This award is not designated with a set-aside requirement, indicating open competition.
Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.93 firm fixed-price delivery order is for the supply of 4566771107 - Atomoxetine HCL 40 mg capsules in quantities of 30s.
The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of 4,566,770,990 units of the medication Atomoxetine HCL 40 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,727.36 and is a firm fixed-price delivery order with a completion date of December 20, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, with a ceiling value of $1,126.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD).
The contract does not have a set-aside designation, indicating it was open to full and open competition. AmerisourceBergen holds a...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of pharmaceutical distributor Amerisourcebergen Corporation. The $1,064.74 firm fixed price award is for the supply of Atomoxetine HCL 40 mg capsules to the Defense Logistics Agency (DLA), which is the logistics combat support agency for the U.S. Department of Defense.
The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued up...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Atomoxetine HCL 10 mg capsules. The contract has a potential value of $1,721.75 and a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA Troop Support...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,714,904 capsules of the pharmaceutical Atomoxetine HCl 40 mg, with a completion date of February 21, 2024 and an award date of February 20, 2024. The potential value of this single award is $1,190.07. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,315.00 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 30S, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...